John G Ullman & Associates Inc Azenta, Inc. Transaction History

John G Ullman & Associates Inc

$631 Million
Q4 2024

A detailed history of John G Ullman & Associates Inc transactions in Azenta, Inc. stock. As of the latest transaction made, John G Ullman & Associates Inc holds 111,825 shares of AZTA stock, worth $5.85 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

111,825

Previous 79,793 40.14%

Holding current value

$5.85 Million

Previous $3.87 Million 44.66%

% of portfolio

0.89%

Previous 0.6%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$40.37 - $51.57 $1.29 Million - $1.65 Million	32,032 Added 40.14%	111,825 $5.59 Million
Q3 2024 Nov 08, 2024	SELL	$45.84 - $62.29 $32,088 - $43,603	-700 Reduced 0.87%	79,793 $3.87 Million
Q2 2024 Aug 08, 2024	SELL	$50.27 - $59.04 $23,878 - $28,044	-475 Reduced 0.59%	80,493 $4.24 Million
Q1 2024 May 06, 2024	SELL	$57.82 - $67.51 $66,493 - $77,636	-1,150 Reduced 1.4%	80,968 $4.88 Million
Q4 2023 Jan 31, 2024	SELL	$44.02 - $66.3 $11,005 - $16,575	-250 Reduced 0.3%	82,118 $5.35 Million
Q3 2023 Nov 01, 2023	BUY	$44.08 - $57.76 $395,573 - $518,338	8,974 Added 12.23%	82,368 $4.13 Million
Q2 2023 Aug 21, 2023	BUY	$36.45 - $46.68 $1.17 Million - $1.49 Million	31,981 Added 77.22%	73,394 $3.43 Million
Q1 2023 May 05, 2023	BUY	$39.51 - $61.95 $49,387 - $77,437	1,250 Added 3.11%	41,413 $1.85 Million
Q4 2022 Feb 08, 2023	SELL	$38.6 - $62.07 $61,760 - $99,312	-1,600 Reduced 3.83%	40,163 $2.34 Million
Q3 2022 Oct 19, 2022	SELL	$42.86 - $77.02 $4,286 - $7,702	-100 Reduced 0.24%	41,763 $1.79 Million
Q1 2022 Apr 29, 2022	SELL	$76.3 - $103.81 $17,472 - $23,772	-229 Reduced 0.54%	41,863 $3.47 Million
Q4 2021 Jan 26, 2022	SELL	$92.98 - $124.15 $4,741 - $6,331	-51 Reduced 0.12%	42,092 $4.34 Million
Q3 2021 Nov 02, 2021	SELL	$77.49 - $109.17 $23,247 - $32,751	-300 Reduced 0.71%	42,143 $4.31 Million
Q2 2021 Jul 23, 2021	SELL	$86.59 - $107.47 $25,977 - $32,241	-300 Reduced 0.7%	42,443 $4.04 Million
Q1 2021 Apr 22, 2021	SELL	$66.32 - $90.93 $754,389 - $1.03 Million	-11,375 Reduced 21.02%	42,743 $3.49 Million
Q4 2020 Feb 05, 2021	SELL	$46.7 - $75.22 $775,220 - $1.25 Million	-16,600 Reduced 23.47%	54,118 $3.67 Million
Q3 2020 Nov 06, 2020	SELL	$42.77 - $56.69 $937,518 - $1.24 Million	-21,920 Reduced 23.66%	70,718 $3.27 Million
Q2 2020 Jul 29, 2020	SELL	$26.54 - $44.24 $11,943 - $19,908	-450 Reduced 0.48%	92,638 $4.1 Million
Q1 2020 Apr 14, 2020	SELL	$22.69 - $44.14 $18,152 - $35,312	-800 Reduced 0.85%	93,088 $2.84 Million
Q4 2019 Jan 29, 2020	SELL	$35.49 - $48.05 $1.43 Million - $1.94 Million	-40,300 Reduced 30.03%	93,888 $3.94 Million
Q3 2019 Oct 21, 2019	SELL	$30.18 - $41.75 $276,358 - $382,304	-9,157 Reduced 6.39%	134,188 $4.97 Million
Q2 2019 Aug 02, 2019	SELL	$29.53 - $41.1 $79,731 - $110,970	-2,700 Reduced 1.85%	143,345 $5.56 Million
Q1 2019 Apr 30, 2019	SELL	$24.38 - $33.75 $21,332 - $29,531	-875 Reduced 0.6%	146,045 $4.28 Million
Q4 2018 Jan 29, 2019	SELL	$23.22 - $35.29 $32,856 - $49,935	-1,415 Reduced 0.95%	146,920 $3.85 Million
Q3 2018 Nov 02, 2018	SELL	$28.71 - $39.6 $2.2 Million - $3.04 Million	-76,801 Reduced 34.11%	148,335 $5.2 Million
Q2 2018 Jul 23, 2018	SELL	$24.88 - $36.36 $44,609 - $65,193	-1,793 Reduced 0.79%	225,136 $7.34 Million
Q1 2018 Apr 19, 2018	SELL	$23.3 - $30.15 $33,295 - $43,084	-1,429 Reduced 0.63%	226,929 $6.15 Million
Q4 2017 Jan 31, 2018	SELL	$22.54 - $34.39 $796,541 - $1.22 Million	-35,339 Reduced 13.4%	228,358 $5.45 Million
Q3 2017 Nov 03, 2017	BUY	$22.6 - $30.36 $5.96 Million - $8.01 Million	263,697	263,697 $8.01 Million

Others Institutions Holding AZTA

# of Institutions

336

Shares Held

49.6M

Call Options Held

186K

Put Options Held

405K

View Full List

About Azenta, Inc.

Ticker AZTA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 75,020,400
Market Cap $3.93B
Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...

More about AZTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.

Account

John G Ullman & Associates Inc Azenta, Inc. Transaction History